Nuvalent Logo

Nuvalent

Targeted cancer therapies

About Nuvalent

Nuvalent is dedicated to creating precisely targeted therapies for cancer patients, overcoming the limitations of existing treatments. With expertise in structure-based design, Nuvalent develops innovative small molecules that offer high target selectivity, reduce resistance, and minimize adverse events. The company is advancing a robust pipeline, including lead programs in ROS1-positive and ALK-positive NSCLC, and multiple discovery-stage research programs.

Overview

  • Website
  • LinkedIn
  • 11-50 employees
  • Founded in 2017
  • 14 active jobs
  • Hiring in:
    • Worldwide
    • 🇺🇸 United States